Overall rank by patents
#47,959
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 9 technology areas, recorded in grant years 2015–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C22B (Production AND Refining OF Metals ; Pretreatment OF RAW Materials).
The verdict
According to USPTO PatentsView, Jiangxi ranks #47,959 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 9 technology areas.
USPTO PatentsView assignee plate
Corpus R47959 · Foreign Corporation #47,959 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Jiangsu Mingteng Health Products Co., Ltd (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Jiangxi Rare Earth… · this assignee
21 score
3D Lighting… · lowest
7 score
What this shows Jiangxi's Innovation Score is 21.0/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Jiangxi Rare Earth and Rare Metals Tungsten Group Corporation is a focused PatentsView assignee: 9 CPC subclasses with 60% of grants classified under C22B (Production AND Refining OF Metals ; Pretreatment OF RAW Materials). Peak complete grant year is 2015 (3 grants) versus a trough of 2 in 2016. By volume, Jiangxi sits between Jiangsu Mingteng Health Products Co., Ltd and Jilin Cofco Biomaterial Co., Ltd.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Jiangsu Mingteng Health Products Co., Ltd
5 patents
Jiangsu Provincial Academy of Environmental Science
5 patents
Jiangsu Yahong Meditech Co., Ltd.
5 patents
Jiangxi Baiying High-Tech Holdings Co., Ltd.
5 patents
Jiangyin Sinbon Electronics Co., Ltd.
5 patents
Jiaxing Explorer Metal Products Co., Ltd.
5 patents
Jikai Biosciences, Inc.
5 patents
Jilin Cofco Biomaterial Co., Ltd
5 patents
Jiangxi Rare Earth and Rare Metals Tungsten Group Corporation
5 patents
What this shows Jiangxi holds 5 patents at rank #48,010, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #48,010 in granted patent volume.
Other assignees with the most granted patents in Jiangxi's primary technology class.
Jiangxi's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
21 8th percentile higher than 8% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 60.0% |
| 2016 | 2 | 40.0% |
Top 9 of 9 technology areas
Overall rank by patents
#47,959
of 49,997 tracked assignees
21.0 out of 100
What to do with this data
Jiangxi Rare Earth and Rare Metals Tungsten Group Corporation's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.